Upregulation of RAS/RAF/ERK and PI3K/PTEN/AKT signaling pathways has been observed in CRC tumors having ERBB2 gene amplification and/or V777L activating mutation.54, 55. This evidence concerns the gene PIK3CA and colorectal carcinoma.